The rationale for including them is there, since several have theoretical links to GLP-1 secretion or metabolism
Mood, energy, and appetite changes should be discussed with a clinician or trial team, especially if they are intense or unexpected
For example, one treatment might be intended to regulate appetite, while another is discussed for body composition, recovery, sleep, or growth hormone signaling
This preserves the natural pulsatile release pattern and negative feedback mechanisms, typically resulting in a safer side effect profile (Prakash & Bhatt, 2013, Indian Journal of Endocrinology and Metabolism )
Clinical Pharmacokinetics, 56(11), 13911401